Clinical trials
Pulmonary Disease, Chronic Obstructive clinical trials
Below are recruiting pulmonary disease, chronic obstructive clinical trials, each written for real people, not researchers. We’re tracking 357 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06944925RecruitingPhase 1
Study of BBT002 for COPD and Nasal Polyps
This trial tests a new drug, BBT002, first in healthy volunteers and then in people with chronic obstructive pulmonary disease (COPD) or chronic sinusitis with nasal polyps. It aims to see if the drug is safe and how it works in the body.
Bowling Green, KentuckyAges 18–80 - NCT05896800Recruiting
Inhaled nitric oxide for moderate to severe COPD symptoms
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
Nanjing, JiangsuAges 40–75 - NCT04220463Recruiting
Hypnosis during noninvasive breathing support for ICU lung illness
This trial tests whether hypnosis can help people in the ICU who need noninvasive breathing support (breathing help without a tube) for breathing flare-ups related to COPD and/or obesity. It aims to make this treatment easier and safer while you are awake.
Rennes, Brittany RegionAges 18 years+ - NCT06892210RecruitingPhase 4
Steroid comparison for COPD flare-ups
This trial compares two common steroids, hydrocortisone and prednisolone, to see which works better for treating COPD flare-ups. It may help you recover faster from a sudden worsening of your breathing.
Rønne, BornholmAges 40 years+ - NCT06883305RecruitingPhase 3
Testing tezepelumab for moderate to severe COPD
This trial tests tezepelumab, an injected medication, for people with moderate to very severe COPD who still have flare-ups despite using standard inhalers. It may help reduce flare-ups and improve breathing for those with higher eosinophil levels.
Foley, AlabamaAges 40–80 - NCT06888557Recruiting
Smartphone help for COPD: improve quality of life
This trial tests a smartphone-based program to help people with COPD manage their condition and feel better. You will use WhatsApp or WeChat to get support and track your activity.
Hong Kong, Hong KongAges 40 years+ - NCT06882863Enrolling by invitation
Study to help reduce sitting in severe COPD
This study tests whether a nurse can help you sit less during the day if you have severe COPD. A nurse will visit you at home for motivational interviews to help you become more active.
RoskildeAges 65 years+ - NCT06878261RecruitingPhase 3
Tezepelumab for moderate to very severe COPD
This study tests a new medication called tezepelumab (given as a shot) to see if it can reduce COPD flare-ups in people with moderate to very severe COPD who have had recent flare-ups despite using inhalers. It may be an option for those with higher levels of eosinophils (a type of white blood cell) in their blood.
Birmingham, AlabamaAges 40–80 - NCT06862206Recruiting
Benralizumab study for severe asthma in China
This study looks at people in China with severe eosinophilic asthma who are starting a new medicine called benralizumab. It will collect information about their symptoms and quality of life to understand who benefits most.
AnhuiAges Any age - NCT06858748Recruiting
Mucus in airways: asthma, COPD, and chronic cough study
This study is looking at how mucus builds up in the airways of people with asthma, COPD, or chronic cough. Researchers will also compare findings to healthy volunteers. The goal is to better understand these conditions and find new ways to help.
Vancouver, British ColumbiaAges 18 years+ - NCT06851195Enrolling by invitation
Electrical stimulation for leg strength in COPD
This trial tests whether a gentle electrical stimulation applied to your leg muscles can help you feel less breathless and less tired during daily activities, and improve your confidence in exercising. It is for people with stable COPD who are already in a pulmonary rehab program.
Kaohsiung, TaiwanAges 18 years+ - NCT06847061Recruiting
Pulmonary rehab for rural COPD patients
This study tests a home-based or remote pulmonary rehabilitation program for people with COPD who live in rural areas. The goal is to help you manage your breathing and stay active, all from home without travel to a medical center.
Scottsdale, ArizonaAges 40 years+ - NCT06827379Enrolling by invitation
Breathing exercise for muscle and nerve health in COPD
This trial tests whether a special breathing exercise (inspiratory muscle training) can improve how your muscles work and your body's automatic responses, like heart rate. It's a one-time session for people with stable COPD.
João Pessoa, ParaíbaAges 40–75 - NCT06625944Recruiting
How viral infections affect lung disease
This study looks at how viral infections impact people with chronic lung conditions like COPD or bronchiectasis. It aims to understand symptoms and triggers better, which could help improve future treatments.
LondonAges 18 years+ - NCT06820749Enrolling by invitationPhase 2
Study of HSK31858 tablets for lung mucus conditions
This trial tests an investigational tablet for people with chronic lung diseases like bronchiectasis, COPD, or asthma who produce at least 10 mL of sputum (mucus coughed up from the lungs) each day. The goal is to see if the drug safely reduces excess airway mucus.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06782724RecruitingPhase 2
Psilocybin therapy for distress in advanced illness
This trial tests whether a single dose of psilocybin (a psychedelic medicine) can help reduce depression and distress in people with advanced lung disease, ALS, multiple sclerosis, or Parkinson's. You would receive preparation, the drug, and follow-up support in a safe, supervised setting.
PragueAges 18 years+ - NCT06780046Recruiting
COPD study for Brazilian patients
This study looks at the health of Brazilian adults with COPD. It aims to understand how the condition affects people and may help improve future treatments.
Aparecida de GoiâniaAges 18 years+ - NCT06776731Recruiting
Does extra oxygen during rehab help lung disease patients?
This study tests whether breathing extra oxygen during outpatient pulmonary rehabilitation helps people with COPD. Participants will have their oxygen levels checked during exercise to see if extra oxygen improves their rehab results.
Winterthur, Canton of ZurichAges 18 years+ - NCT06755008Recruiting
Cell repair for lung health in COPD
This study tests whether special stem cells can help repair lung damage in people with COPD. It may help us understand how to improve lung function for those who smoke or have smoked.
Montpellier, HéraultAges 18 years+ - NCT06756646Recruiting
Aerobic exercise and BFRT for COPD patients
This trial tests if adding a special band (BFRT) to walking or biking can help people with COPD breathe better and get stronger. It may be a good option if you have moderate to very severe COPD and haven't been in a rehab program lately.
Tainan, TaiwanAges 30–85 - NCT06751537Recruiting
Testing a wearable device for COPD severity
This trial tests a wearable device (WearME) that tracks your breathing and activity to see how well it can measure COPD severity. It may help you and your doctor better understand your lung function at home.
Baltimore, MarylandAges 21–100 - NCT06749262Recruiting
Inclined vs. standard exercise for COPD
This study compares walking on an incline to standard walking for people with COPD. It aims to find which exercise method is better for improving breathing and mobility.
Omaha, NebraskaAges 45–80 - NCT06717659Recruiting
Probiotics for lung rehab in COPD patients
This trial tests if adding probiotics (healthy bacteria you take as a supplement) to your regular lung rehab program helps people with COPD breathe better and feel stronger.
New Taipei CityAges 18 years+ - NCT06702696Recruiting
Study on aronia berries for COPD inflammation
This trial tests whether eating aronia berries (black chokeberries) can help reduce inflammation in people with COPD. It may offer a natural way to manage COPD symptoms.
Istanbul, ZeytinburnuAges 50–80
Hear when a new Pulmonary Disease, Chronic Obstructive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary disease, chronic obstructive?
- Yes. Clin2 currently lists 357 recruiting pulmonary disease, chronic obstructive studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary disease, chronic obstructive trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary disease, chronic obstructive trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.